|
1
|
Kumar SK, Rajkumar SV, Dispenzieri A, Lacy
MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust
JA, et al: Improved survival in multiple myeloma and the impact of
novel therapies. Blood. 111:2516–2520. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gkotzamanidou M, Christoulas D, Souliotis
VL, Papatheodorou A, Dimopoulos MA and Terpos E: Angiogenic
cytokines profile in smoldering multiple myeloma: No difference
compared to MGUS but altered compared to symptomatic myeloma. Med
Sci Monit. 19:1188–1194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Accardi F, Toscani D, Bolzoni M, Dalla
Palma B, Aversa F and Giuliani N: Mechanism of action of bortezomib
and the new proteasome inhibitors on myeloma cells and the bone
microenvironment: Impact on myeloma-induced alterations of bone
remodeling. BioMed Res Int. 2015:1724582015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matthes T, Manfroi B, Zeller A,
Dunand-Sauthier I, Bogen B and Huard B: Autocrine amplification of
immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone
marrow. Leukemia. 29:1882–1890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dankbar B, Padró T, Leo R, Feldmann B,
Kropff M, Mesters RM, Serve H, Berdel WE and Kienast J: Vascular
endothelial growth factor and interleukin-6 in paracrine
tumor-stromal cell interactions in multiple myeloma. Blood.
95:2630–2636. 2000.PubMed/NCBI
|
|
6
|
van der Pol E, Böing AN, Harrison P, Sturk
A and Nieuwland R: Classification, functions, and clinical
relevance of extracellular vesicles. Pharmacol Rev. 64:676–705.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Todorova D, Simoncini S, Lacroix R,
Sabatier F and Dignat-George F: Extracellular Vesicles in
Angiogenesis. Circ Res. 120:1658–1673. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
EL Andaloussi S, Mäger I, Breakefield XO
and Wood MJ: Extracellular vesicles: Biology and emerging
therapeutic opportunities. Nat Rev Drug Discov. 12:347–357. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Canella A, Harshman SW, Radomska HS,
Freitas MA and Pichiorri F: The potential diagnostic power of
extracellular vesicle analysis for multiple myeloma. Expert Rev Mol
Diagn. 16:277–284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deregibus MC, Cantaluppi V, Calogero R, Lo
Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B and Camussi G:
Endothelial progenitor cell derived microvesicles activate an
angiogenic program in endothelial cells by a horizontal transfer of
mRNA. Blood. 110:2440–2448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zou X, Gu D, Xing X, Cheng Z, Gong D,
Zhang G and Zhu Y: Human mesenchymal stromal cell-derived
extracellular vesicles alleviate renal ischemic reperfusion injury
and enhance angiogenesis in rats. Am J Transl Res. 8:4289–4299.
2016.PubMed/NCBI
|
|
12
|
Lombardo G, Dentelli P, Togliatto G, Rosso
A, Gili M, Gallo S, Deregibus MC, Camussi G and Brizzi MF:
Activated Stat5 trafficking via endothelial cell-derived
extracellular vesicles controls IL-3 pro-angiogenic paracrine
action. Sci Rep. 6:256892016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson JD, Johansson HJ, Graham CS,
Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS,
Bardini RL, Contreras Z, et al: Comprehensive proteomic analysis of
mesenchymal stem cell exosomes reveals modulation of angiogenesis
via nuclear factor-kappab signaling. Stem Cells. 34:601–613. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Zhu XJ, Zeng C, Wu PH, Wang HX,
Chen ZC and Li QB: Microvesicles secreted from human multiple
myeloma cells promote angiogenesis. Acta Pharmacol Sin. 35:230–238.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li ZW, Chen H, Campbell RA, Bonavida B and
Berenson JR: NF-kappaB in the pathogenesis and treatment of
multiple myeloma. Curr Opin Hematol. 15:391–399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chilov D, Kukk E, Taira S, Jeltsch M,
Kaukonen J, Palotie A, Joukov V and Alitalo K: Genomic organization
of human and mouse genes for vascular endothelial growth factor C.
J Biol Chem. 272:25176–25183. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cramer M, Nagy I, Murphy BJ, Gassmann M,
Hottiger MO, Georgiev O and Schaffner W: NF-kappaB contributes to
transcription of placenta growth factor and interacts with metal
responsive transcription factor-1 in hypoxic human cells. Biol
Chem. 386:865–872. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nencioni A, Grünebach F, Patrone F,
Ballestrero A and Brossart P: Proteasome inhibitors: Antitumor
effects and beyond. Leukemia. 21:30–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Luisi A, Ferrucci A, Coluccia AM, Ria
R, Moschetta M, de Luca E, Pieroni L, Maffia M, Urbani A, Di Pietro
G, et al: Lenalidomide restrains motility and overangiogenic
potential of bone marrow endothelial cells in patients with active
multiple myeloma. Clin Cancer Res. 17:1935–1946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singhal S and Mehta J: Lenalidomide in
myeloma. Curr Treat Options Oncol. 8:154–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fremder E, Munster M, Aharon A, Miller V,
Gingis-Velitski S, Voloshin T, Alishekevitz D, Bril R, Scherer SJ,
Loven D, et al: Tumor-derived microparticles induce bone
marrow-derived cell mobilization and tumor homing: A process
regulated by osteopontin. Int J Cancer. 135:270–281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Munster M, Fremder E, Miller V, Ben-Tsedek
N, Davidi S, Scherer SJ and Shaked Y: Anti-VEGF-A affects the
angiogenic properties of tumor-derived microparticles. PLoS One.
9:e959832014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zarfati M, Katz T, Avivi I, Brenner B and
Aharon A: PO-45 - The role of microvesicles in multiple myeloma
progression. Thromb Res. 140 Suppl 1:S1932016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun L, Wang HX, Zhu XJ, Wu PH, Chen WQ,
Zou P, Li QB and Chen ZC: Serum deprivation elevates the levels of
microvesicles with different size distributions and selectively
enriched proteins in human myeloma cells in vitro. Acta Pharmacol
Sin. 35:381–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma GF, Chen S, Yin L, Gao XD and Yao WB:
Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage
migration in vitro via the NF-κB pathway. Acta Pharmacol Sin.
35:195–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ribatti D and Vacca A: The role of
microenvironment in tumor angiogenesis. Genes Nutr. 3:29–34. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klein B: Positioning NK-kappaB in multiple
myeloma. Blood. 115:3422–3424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Podar K and Anderson KC: Inhibition of
VEGF signaling pathways in multiple myeloma and other malignancies.
Cell Cycle. 6:538–542. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thompson CA, Purushothaman A, Ramani VC,
Vlodavsky I and Sanderson RD: Heparanase regulates secretion,
composition, and function of tumor cell-derived exosomes. J Biol
Chem. 288:10093–10099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mineo M, Garfield SH, Taverna S, Flugy A,
De Leo G, Alessandro R and Kohn EC: Exosomes released by K562
chronic myeloid leukemia cells promote angiogenesis in a
Src-dependent fashion. Angiogenesis. 15:33–45. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roccaro AM, Sacco A, Maiso P, Azab AK, Tai
YT, Reagan M, Azab F, Flores LM, Campigotto F, Weller E, et al: BM
mesenchymal stromal cell-derived exosomes facilitate multiple
myeloma progression. J Clin Invest. 123:1542–1555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brill A, Dashevsky O, Rivo J, Gozal Y and
Varon D: Platelet-derived microparticles induce angiogenesis and
stimulate post-ischemic revascularization. Cardiovasc Res.
67:30–38. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang B, Wu X, Zhang X, Sun Y, Yan Y, Shi
H, Zhu Y, Wu L, Pan Z, Zhu W, et al: Human umbilical cord
mesenchymal stem cell exosomes enhance angiogenesis through the
Wnt4/β-catenin pathway. Stem Cells Transl Med. 4:513–522. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shabbir A, Cox A, Rodriguez-Menocal L,
Salgado M and Van Badiavas E: Mesenchymal stem cell exosomes induce
proliferation and migration of normal and chronic wound
fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev.
24:1635–1647. 2015. View Article : Google Scholar : PubMed/NCBI
|
